<p>LaSalle St. Investment Advisors LLC 在第一季度將其在強生（NYSE:JNJ - 免費報告）的股份增加了 16.8%，根據該公司最近向證券交易委員會提交的 13F 表格。該基金在此期間額外購買了 1,776 股後，持有該公司 12,356 股股票。截至其最近向證券交易委員會提交的文件，LaSalle St. Investment Advisors LLC 在強生的持股價值為 2,049,000 美元。</p>
<p>獲取 <strong>強生</strong> 的提醒：</p>
<ul>
<li>擔心反彈消退？考慮這三隻分紅股票</li>
</ul>
<p>其他大型投資者最近也調整了對該公司的持股。Elios Financial Group Inc. 在第一季度將其在強生的股份增加了 1.5%。Elios Financial Group Inc. 目前持有 4,496 股該公司股票，價值 746,000 美元，此前在此期間額外購買了 66 股。Atlantic Family Wealth LLC 在第一季度將其在強生的股份增加了 4.4%。Atlantic Family Wealth LLC 目前持有 1,603 股該公司股票，價值 266,000 美元，此前在上個季度額外購買了 67 股。MBA Advisors LLC 在第一季度將其在強生的股份增加了 1.2%。MBA Advisors LLC 目前持有 5,553 股該公司股票，價值 921,000 美元，此前在上個季度額外購買了 68 股。Sovereign Financial Group Inc. 在第一季度將其在強生的股份增加了 1.8%。Sovereign Financial Group Inc. 目前持有 3,928 股該公司股票，價值 651,000 美元，此前在上個季度額外購買了 69 股。最後，Nabity Jensen Investment Management Inc 在第一季度將其在強生的股份增加了 1.5%。Nabity Jensen Investment Management Inc 目前持有 4,624 股該公司股票，價值 767,000 美元，此前在上個季度額外購買了 69 股。目前 69.55% 的股票由機構投資者和對沖基金持有。</p>
<h2>華爾街分析師觀點</h2>
<p>幾家券商最近對 JNJ 進行了評論。Wall Street Zen 在 7 月 18 日的研究報告中將強生的評級從 “強力買入” 下調至 “買入”。瑞銀集團在 7 月 17 日的研究報告中將強生的目標價從 180.00 美元上調至 190.00 美元，並給予該公司 “買入” 評級。Piper Sandler 在 7 月 17 日的研究報告中重申了對強生股票的 “增持” 評級。美國銀行在 7 月 17 日的研究報告中將強生的目標價從 161.00 美元上調至 175.00 美元，並給予該股票 “中性” 評級。最後，Benchmark 在 4 月 24 日的報告中將強生升級為 “強力買入” 評級。九位股票研究分析師對該股票給予了持有評級，十位給予了買入評級，兩位給予了強力買入評級。根據 MarketBeat 的數據，該公司目前的共識評級為 “適度買入”，平均目標價為 174.50 美元。</p>
<ul>
<li>三隻強勁盈利的高分紅股票</li>
</ul>
<p><strong>獲取我們關於強生的最新股票報告</strong></p>
<h2>強生股票表現</h2>
<p>強生的股票在週五開盤價為 171.41 美元。該公司的債務與股本比率為 0.50，流動比率為 1.01，速動比率為 0.76。強生的年內最低價為 140.68 美元，年內最高價為 172.18 美元。該公司的 50 日移動平均價格為 158.89 美元，200 日移動平均價格為 157.27 美元。該公司的市值為 4,128.1 億美元，市盈率為 18.33，市盈增長比率為 2.17，貝塔值為 0.41。</p>
<ul>
<li>四隻主要股票上調 2025 年指引，分析師目標上升</li>
</ul>
<p>強生（NYSE:JNJ - 獲取免費報告）最近於 7 月 16 日發佈了季度財報。該公司報告季度每股收益為 2.77 美元，超出分析師一致預期的 2.68 美元，超出 0.09 美元。該公司季度收入為 237.4 億美元，而分析師預期為 228.5 億美元。強生的股本回報率為 32.49%，淨利潤率為 25.00%。強生的收入較去年同期增長了 5.8%。去年同期，該公司每股收益為 2.82 美元。整體而言，分析師預計強生在當前年度的每股收益將達到 10.58 美元。</p>
<h2>強生分紅公告</h2>
<p>該公司最近還宣佈了一項季度分紅，將於 9 月 9 日（星期二）支付。8 月 26 日（星期二）的股東將獲得 1.30 美元的分紅。這相當於每年 5.20 美元的分紅，收益率為 3.0%。該分紅的除息日為 8 月 26 日（星期二）。強生的分紅支付比率（DPR）目前為 55.61%。</p>
<h2>強生簡介</h2>
<p>（免費報告）</p>
<p>強生是一家控股公司，專注於醫療保健領域的產品研究、開發、製造和銷售。它通過創新藥物和醫療技術兩個部門運營。創新藥物部門專注於免疫學、傳染病、神經科學、腫瘤學、心血管和代謝以及肺動脈高壓。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們更看好的股票超過強生</li>
<li>如何計算股票利潤</li>
<li>三隻推動下一次科技革命的人工智能基礎設施股票</li>
<li>如何使用 MarketBeat 股票篩選器</li>
<li>為什麼單片電源的收益和指引引發了反彈</li>
<li>什麼是道瓊斯狗策略？概述和示例</li>
<li>AppLovin 的第二季度業績不佳讓市場感到恐慌，但華爾街卻加倍下注</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg"/></p>
<p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1000 美元在強生嗎？</h2>
<p>在考慮強生之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而強生並不在名單上。</p>
<p>雖然強生目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

強生

<p>LaSalle St. Investment Advisors LLC 在第一季度將其在強生（NYSE: JNJ）的持股增加了 16.8%，額外購買了 1,776 股，總持股達到 12,356 股，價值為 2,049,000 美元。其他投資者也調整了他們的持股。分析師對 JNJ 的評級意見不一，普遍評級為 “適度買入”，平均目標價為 174.50 美元。JNJ 的股票開盤價為 171.41 美元，市值為 4,128.1 億美元，市盈率為 18.33。該公司報告上個季度每股收益為 2.77 美元，超出預期</p>

<p>LaSalle St. Investment Advisors LLC grew its stake in Johnson &amp; Johnson (NYSE:JNJ - Free Report) by 16.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,356 shares of the company's stock after acquiring an additional 1,776 shares during the period. LaSalle St. Investment Advisors LLC's holdings in Johnson &amp; Johnson were worth $2,049,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>LaSalle St. Investment Advisors LLC 在第一季度將其在強生（NYSE:JNJ - 免費報告）的股份增加了 16.8%，根據該公司最近向證券交易委員會提交的 13F 表格。該基金在此期間額外購買了 1,776 股後，持有該公司 12,356 股股票。截至其最近向證券交易委員會提交的文件，LaSalle St. Investment Advisors LLC 在強生的持股價值為 2,049,000 美元。</p>
</div><p>Get <strong>Johnson &amp; Johnson</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>強生</strong> 的提醒：</p>
</div><ul>
<li>Worried About a Fading Rally? Consider These 3 Dividend Stocks</li>
</ul>
<div class="lb-trans"><ul>
<li>擔心反彈消退？考慮這三隻分紅股票</li>
</ul>
</div><p>Other large investors also recently modified their holdings of the company. Elios Financial Group Inc. boosted its stake in Johnson &amp; Johnson by 1.5% in the 1st quarter. Elios Financial Group Inc. now owns 4,496 shares of the company's stock valued at $746,000 after purchasing an additional 66 shares during the period. Atlantic Family Wealth LLC boosted its position in shares of Johnson &amp; Johnson by 4.4% during the 1st quarter. Atlantic Family Wealth LLC now owns 1,603 shares of the company's stock worth $266,000 after acquiring an additional 67 shares in the last quarter. MBA Advisors LLC increased its stake in Johnson &amp; Johnson by 1.2% in the first quarter. MBA Advisors LLC now owns 5,553 shares of the company's stock valued at $921,000 after acquiring an additional 68 shares during the last quarter. Sovereign Financial Group Inc. lifted its stake in Johnson &amp; Johnson by 1.8% during the first quarter. Sovereign Financial Group Inc. now owns 3,928 shares of the company's stock worth $651,000 after purchasing an additional 69 shares during the last quarter. Finally, Nabity Jensen Investment Management Inc increased its stake in shares of Johnson &amp; Johnson by 1.5% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 4,624 shares of the company's stock valued at $767,000 after purchasing an additional 69 shares during the last quarter. 69.55% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他大型投資者最近也調整了對該公司的持股。Elios Financial Group Inc. 在第一季度將其在強生的股份增加了 1.5%。Elios Financial Group Inc. 目前持有 4,496 股該公司股票，價值 746,000 美元，此前在此期間額外購買了 66 股。Atlantic Family Wealth LLC 在第一季度將其在強生的股份增加了 4.4%。Atlantic Family Wealth LLC 目前持有 1,603 股該公司股票，價值 266,000 美元，此前在上個季度額外購買了 67 股。MBA Advisors LLC 在第一季度將其在強生的股份增加了 1.2%。MBA Advisors LLC 目前持有 5,553 股該公司股票，價值 921,000 美元，此前在上個季度額外購買了 68 股。Sovereign Financial Group Inc. 在第一季度將其在強生的股份增加了 1.8%。Sovereign Financial Group Inc. 目前持有 3,928 股該公司股票，價值 651,000 美元，此前在上個季度額外購買了 69 股。最後，Nabity Jensen Investment Management Inc 在第一季度將其在強生的股份增加了 1.5%。Nabity Jensen Investment Management Inc 目前持有 4,624 股該公司股票，價值 767,000 美元，此前在上個季度額外購買了 69 股。目前 69.55% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>Several brokerages recently commented on JNJ. Wall Street Zen lowered Johnson &amp; Johnson from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Friday, July 18th. UBS Group lifted their price objective on Johnson &amp; Johnson from $180.00 to $190.00 and gave the company a &#34;buy&#34; rating in a research note on Thursday, July 17th. Piper Sandler reiterated an &#34;overweight&#34; rating on shares of Johnson &amp; Johnson in a research report on Thursday, July 17th. Bank of America lifted their price objective on Johnson &amp; Johnson from $161.00 to $175.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, July 17th. Finally, Benchmark upgraded Johnson &amp; Johnson to a &#34;strong-buy&#34; rating in a report on Thursday, April 24th. Nine equities research analysts have rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $174.50.</p>
<div class="lb-trans"><p>幾家券商最近對 JNJ 進行了評論。Wall Street Zen 在 7 月 18 日的研究報告中將強生的評級從 “強力買入” 下調至 “買入”。瑞銀集團在 7 月 17 日的研究報告中將強生的目標價從 180.00 美元上調至 190.00 美元，並給予該公司 “買入” 評級。Piper Sandler 在 7 月 17 日的研究報告中重申了對強生股票的 “增持” 評級。美國銀行在 7 月 17 日的研究報告中將強生的目標價從 161.00 美元上調至 175.00 美元，並給予該股票 “中性” 評級。最後，Benchmark 在 4 月 24 日的報告中將強生升級為 “強力買入” 評級。九位股票研究分析師對該股票給予了持有評級，十位給予了買入評級，兩位給予了強力買入評級。根據 MarketBeat 的數據，該公司目前的共識評級為 “適度買入”，平均目標價為 174.50 美元。</p>
</div><ul>
<li>3 Big Dividend Plays With Strong Earnings to Back Them</li>
</ul>
<div class="lb-trans"><ul>
<li>三隻強勁盈利的高分紅股票</li>
</ul>
</div><p><strong>Get Our Latest Stock Report on Johnson &amp; Johnson</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於強生的最新股票報告</strong></p>
</div><h2>Johnson &amp; Johnson Stock Performance</h2>
<div class="lb-trans"><h2>強生股票表現</h2>
</div><p>Shares of JNJ opened at $171.41 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.01 and a quick ratio of 0.76. Johnson &amp; Johnson has a one year low of $140.68 and a one year high of $172.18. The company's fifty day moving average price is $158.89 and its 200 day moving average price is $157.27. The company has a market capitalization of $412.81 billion, a PE ratio of 18.33, a price-to-earnings-growth ratio of 2.17 and a beta of 0.41.</p>
<div class="lb-trans"><p>強生的股票在週五開盤價為 171.41 美元。該公司的債務與股本比率為 0.50，流動比率為 1.01，速動比率為 0.76。強生的年內最低價為 140.68 美元，年內最高價為 172.18 美元。該公司的 50 日移動平均價格為 158.89 美元，200 日移動平均價格為 157.27 美元。該公司的市值為 4,128.1 億美元，市盈率為 18.33，市盈增長比率為 2.17，貝塔值為 0.41。</p>
</div><ul>
<li>4 Major Stocks Raise 2025 Guidance, Analyst Targets Rise</li>
</ul>
<div class="lb-trans"><ul>
<li>四隻主要股票上調 2025 年指引，分析師目標上升</li>
</ul>
</div><p>Johnson &amp; Johnson (NYSE:JNJ - Get Free Report) last released its quarterly earnings results on Wednesday, July 16th. The company reported $2.77 EPS for the quarter, topping analysts' consensus estimates of $2.68 by $0.09. The company had revenue of $23.74 billion for the quarter, compared to analyst estimates of $22.85 billion. Johnson &amp; Johnson had a return on equity of 32.49% and a net margin of 25.00%. Johnson &amp; Johnson's revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm posted $2.82 earnings per share. As a group, analysts expect that Johnson &amp; Johnson will post 10.58 earnings per share for the current year.</p>
<div class="lb-trans"><p>強生（NYSE:JNJ - 獲取免費報告）最近於 7 月 16 日發佈了季度財報。該公司報告季度每股收益為 2.77 美元，超出分析師一致預期的 2.68 美元，超出 0.09 美元。該公司季度收入為 237.4 億美元，而分析師預期為 228.5 億美元。強生的股本回報率為 32.49%，淨利潤率為 25.00%。強生的收入較去年同期增長了 5.8%。去年同期，該公司每股收益為 2.82 美元。整體而言，分析師預計強生在當前年度的每股收益將達到 10.58 美元。</p>
</div><h2>Johnson &amp; Johnson Dividend Announcement</h2>
<div class="lb-trans"><h2>強生分紅公告</h2>
</div><p>The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 26th will be given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend is Tuesday, August 26th. Johnson &amp; Johnson's dividend payout ratio (DPR) is currently 55.61%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度分紅，將於 9 月 9 日（星期二）支付。8 月 26 日（星期二）的股東將獲得 1.30 美元的分紅。這相當於每年 5.20 美元的分紅，收益率為 3.0%。該分紅的除息日為 8 月 26 日（星期二）。強生的分紅支付比率（DPR）目前為 55.61%。</p>
</div><h2>Johnson &amp; Johnson Profile</h2>
<div class="lb-trans"><h2>強生簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Johnson &amp; Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.</p>
<div class="lb-trans"><p>強生是一家控股公司，專注於醫療保健領域的產品研究、開發、製造和銷售。它通過創新藥物和醫療技術兩個部門運營。創新藥物部門專注於免疫學、傳染病、神經科學、腫瘤學、心血管和代謝以及肺動脈高壓。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Johnson &amp; Johnson</li>
<li>How to Calculate Stock Profit</li>
<li>3 AI Infrastructure Stocks Powering the Next Tech Revolution</li>
<li>How to Use the MarketBeat Stock Screener</li>
<li>Why Monolithic Power's Earnings and Guidance Ignited a Rally</li>
<li>What is the Dogs of the Dow Strategy? Overview and Examples</li>
<li>AppLovin’s Q2 Miss Spooks Market, But Wall Street Doubles Down</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過強生</li>
<li>如何計算股票利潤</li>
<li>三隻推動下一次科技革命的人工智能基礎設施股票</li>
<li>如何使用 MarketBeat 股票篩選器</li>
<li>為什麼單片電源的收益和指引引發了反彈</li>
<li>什麼是道瓊斯狗策略？概述和示例</li>
<li>AppLovin 的第二季度業績不佳讓市場感到恐慌，但華爾街卻加倍下注</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=JNJ"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Johnson &amp; Johnson Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在強生嗎？</h2>
</div><p>Before you consider Johnson &amp; Johnson, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮強生之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson &amp; Johnson wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而強生並不在名單上。</p>
</div><p>While Johnson &amp; Johnson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然強生目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

LaSalle St. Investment Advisors LLC 收購了強生公司（紐約證券交易所代碼：JNJ）的 1,776 股股票